Literature DB >> 28191786

Quantifying the potential pathways and locations of Rift Valley fever virus entry into the United States.

A J Golnar1, R C Kading2, G L Hamer1.   

Abstract

The global invasion of West Nile virus, chikungunya virus and Zika virus in the past two decades suggests an increasing rate of mosquito-borne virus (arbovirus) dispersal. Rift Valley fever virus (RVFV) is an arbovirus identified as a high-consequence threat to the United States (USA) because of the severe economic and health consequences associated with disease. Numerous studies demonstrate that the USA is receptive to RVFV transmission based on the widespread presence of competent mosquito species and vertebrate species. In this study, the potential pathways and locations of RVFV entry into the USA were quantitatively estimated to support a priori surveillance and RVFV prevention strategies. International movement data, ecological data and epidemiological data were combined to estimate the number of RVFV-infected mosquitoes entering the USA. Results suggest infected humans travelling by plane pose the highest risk of importing RVFV into the USA, followed by the unintentional transport of infected adult mosquitoes by ship and airplane. Furthermore, New York, New York, Washington DC, Atlanta, Georgia, and Houston, Texas, are implicated as the most likely regions of RVFV entry. Results are interpreted and discussed to support the prediction and mitigation of RVFV spread to the USA.
© 2017 The Authors. Transboundary and Emerging Diseases Published by Blackwell Verlag GmbH.

Entities:  

Keywords:  Emerging Disease; Rift Valley fever; arboviruses; modelling; mosquitoes; prevention and control; vector biology

Mesh:

Year:  2017        PMID: 28191786     DOI: 10.1111/tbed.12608

Source DB:  PubMed          Journal:  Transbound Emerg Dis        ISSN: 1865-1674            Impact factor:   5.005


  12 in total

Review 1.  Recent advances in the development of antiviral therapeutics for Rift Valley fever virus infection.

Authors:  Colm Atkins; Alexander N Freiberg
Journal:  Future Virol       Date:  2017-10-23       Impact factor: 1.831

2.  Environmental limits of Rift Valley fever revealed using ecoepidemiological mechanistic models.

Authors:  Giovanni Lo Iacono; Andrew A Cunningham; Bernard Bett; Delia Grace; David W Redding; James L N Wood
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-18       Impact factor: 11.205

3.  Alterations in the host transcriptome in vitro following Rift Valley fever virus infection.

Authors:  Chelsea Pinkham; Bibha Dahal; Cynthia L de la Fuente; Nicole Bracci; Brett Beitzel; Michael Lindquist; Aura Garrison; Connie Schmaljohn; Gustavo Palacios; Aarthi Narayanan; Catherine E Campbell; Kylene Kehn-Hall
Journal:  Sci Rep       Date:  2017-10-30       Impact factor: 4.379

Review 4.  Current Status of Rift Valley Fever Vaccine Development.

Authors:  Bonto Faburay; Angelle Desiree LaBeaud; D Scott McVey; William C Wilson; Juergen A Richt
Journal:  Vaccines (Basel)       Date:  2017-09-19

5.  Susceptibility of White-Tailed Deer to Rift Valley Fever Virus.

Authors:  William C Wilson; In Joong Kim; Jessie D Trujillo; Sun Young Sunwoo; Leela E Noronha; Kinga Urbaniak; D Scott McVey; Barbara S Drolet; Igor Morozov; Bonto Faburay; Erin E Schirtzinger; Tammy Koopman; Sabarish V Indran; Velmurugan Balaraman; Juergen A Richt
Journal:  Emerg Infect Dis       Date:  2018-09       Impact factor: 6.883

6.  Tracking Rift Valley fever: From Mali to Europe and other countries, 2016.

Authors:  Christelle Tong; Emilie Javelle; Gilda Grard; Aissata Dia; Constance Lacrosse; Toscane Fourié; Patrick Gravier; Stéphanie Watier-Grillot; Renaud Lancelot; Franck Letourneur; Frédéric Comby; Martin Grau; Lionel Cassou; Jean-Baptiste Meynard; Sébastien Briolant; Isabelle Leparc-Goffart; Vincent Pommier de Santi
Journal:  Euro Surveill       Date:  2019-02

Review 7.  Livestock Challenge Models of Rift Valley Fever for Agricultural Vaccine Testing.

Authors:  Andrea Louise Kroeker; Shawn Babiuk; Bradley S Pickering; Juergen A Richt; William C Wilson
Journal:  Front Vet Sci       Date:  2020-05-27

8.  Galidesivir limits Rift Valley fever virus infection and disease in Syrian golden hamsters.

Authors:  Jonna B Westover; Amanda Mathis; Ray Taylor; Luci Wandersee; Kevin W Bailey; Eric J Sefing; Brady T Hickerson; Kie-Hoon Jung; William P Sheridan; Brian B Gowen
Journal:  Antiviral Res       Date:  2018-06-01       Impact factor: 5.970

Review 9.  Rift valley fever: diagnostic challenges and investment needs for vaccine development.

Authors:  Velislava Petrova; Paul Kristiansen; Gunnstein Norheim; Solomon A Yimer
Journal:  BMJ Glob Health       Date:  2020-08

Review 10.  Advanced surveillance and preparedness to meet a new era of invasive vectors and emerging vector-borne diseases.

Authors:  Rebekah C Kading; Andrew J Golnar; Sarah A Hamer; Gabriel L Hamer
Journal:  PLoS Negl Trop Dis       Date:  2018-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.